Abstract
Objectives
We assessed the antibiotic patterns of use and geographical distribution of prevalence and consumption by age in 15 Local Health Units (LHUs) of Italy’s Lombardy region.
Methods
A retrospective analysis of reimbursement data for the community-dwelling population in 2005 was performed. Prescriptions reimbursed by the National Health System and consumption as defined daily doses (DDD) per 1,000 inhabitants per day (DID) were analyzed. A logistic regression was performed to evaluate the association between antibiotic drug prescription and age, gender, and LHU of residence of the population.
Results
During 2005, a total of 3,120,851 people (34% of the population) received at least one antibiotic drug prescription. The highest prescription prevalence was observed in the 0–17 and 80 or more years age ranges (41.6 and 41.9%, respectively). Large differences were found in the prevalence rates between different LHUs (ranging from 28.7% in Milan to 39.4% in Brescia) and in DID (ranging from 12.6 DID in Sondrio to 18.9 DID in Brescia). The age and residence of the population were the main determinants of drug exposure. In particular, patients aged <18 years (odds ratio [OR] = 1.73; 95% confidence interval [CI] 1.73, 1.74), aged 65 years or older (OR = 1.64; 95% CI 1.63, 1.65), and those that live in Brescia (OR = 1.66; 95% CI 1.65, 1.66) had a statistically significant higher risk of antibiotic drug exposure.
Conclusions
The observed intra-regional differences underline the need for a careful monitoring with the aim to reduce antibiotic resistance and improve the rational use of drugs.
Similar content being viewed by others
References
Muller A, Coenen S, Monnet DL, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998–2005. Euro Surveill. 2007;12:E071011.1. Available online: http://www.eurosurveillance.org/viewarticle.aspx?articleid=3284
Ferech M, Coenen S, Malhotra-Kumar S, et al. ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006;58:401–7.
Goossens H, Ferech M, Vander Stichele RH, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–87.
van de Sande-Bruinsma N, Grundmann H, Verloo D, et al. European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14:1722–30.
Jensen US, Skjøt-Rasmussen L, Olsen SS, et al. Consequences of increased antibacterial consumption and change in pattern of antibacterial use in Danish hospitals. J Antimicrob Chemother. 2009;63:812–5.
Hillier S, Roberts Z, Dunstan F, et al. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case–control study. J Antimicrob Chemother. 2007;60:92–9.
Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
Bowlware KL, Stull T. Antibacterial agents in pediatrics. Infect Dis Clin North Am. 2004;18:513–31.
Nicolle LE. UTIs. In: Evans JG, Williams TF, Beattie BL, Michel J-P, Wilcock GR, editors. Oxford textbook of geriatric medicine. 2nd ed. Oxford: Oxford University Press; 2000. p. 700–10.
Michel JP, Lesourd B, Conne P, et al. Prevalence of infections and their risk factors in geriatric institutions: a one-day multicentre survey. Bull World Health Organ. 1991;69:35–41.
Smith MA, Duke WM. A retrospective review of nosocomial infections in an acute rehabilitative and chronic population at a large skilled nursing facility. J Am Geriatr Soc. 1994;42:45–9.
Nyquist AC, Gonzales R, Steiner JF, et al. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875–7.
Jacobs RF. Judicious use of antibiotics for common pediatric respiratory infections. Pediatr Infect Dis J. 2000;19:938–43.
European Commission. Antimicrobial resistance. Eurobarometer 338/Wave 72.5—TNS Opinion and Social. Luxembourg, 2010. Available from: http://ec.europa.eu/health/antimicrobial_resistance/docs/ebs_338_en.pdf.
Pichichero ME. Dynamics of antibiotic prescribing for children. JAMA. 2002;287:3133–5.
Corrao G, Zambon A, Bertù L, et al. Evidence of tendinitis provoked by fluoroquinolone treatment: a case–control study. Drug Saf. 2006;29:889–96.
Coenen S, Costers M, Goossens H. Comment on: Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother. 2007;60:179–80.
Cizman M, Srovin T, Pokorn M, et al. Analysis of the causes and consequences of decreased antibiotic consumption over the last 5 years in Slovenia. J Antimicrob Chemother. 2005;55:758–63.
Goossens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol. 2006;62:373–9.
Coenen S, Costers M, De Corte S, et al. The first European Antibiotic Awareness Day after a decade of improving outpatient antibiotic use in Belgium. Acta Clin Belg. 2008;63:296–300.
Sabuncu E, David J, Bernède-Bauduin C, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Med. 2009;6:e1000084.
Malmvall BE, Mölstad S, Darelid J, et al. Reduction of antibiotics sales and sustained low incidence of bacterial resistance: report on a broad approach during 10 years to implement evidence-based indications for antibiotic prescribing in Jönköping County, Sweden. Qual Manag Health Care. 2007;16:60–7.
Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA. 2002;287:3103–9.
Weissman J, Besser RE. Promoting appropriate antibiotic use for pediatric patients: a social ecological framework. Semin Pediatr Infect Dis. 2004;15:41–51.
Orzella L, Chini F, Giorgi Rossi P, et al. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy. Health Policy. 2010;95:236–44.
Nitzan O, Low M, Lavi I, et al. Variability in outpatient antimicrobial consumption in Israel. Infection. 2010;38:12–8.
Kern WV, de With K, Nink K, et al. Regional variation in outpatient antibiotic prescribing in Germany. Infection. 2006;34:269–73.
Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy. 2006;78:77–92.
Davey P, Ferech M, Ansari F, et al. Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother. 2008;62:1441–7.
Osservatorio Nazionale sull’Impiego dei Medicinali (OsMed). L’uso dei farmaci in Italia. Rapporto Nazionale anno 2009.
Ministero della Salute. Home page: http://www.salute.gov.it/servizio/sezSis.jsp?label=elenchi.
Percudani M, Barbui C, Fortino I, et al. Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord. 2004;83:169–75.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2007. Oslo, 2006. Available at: http://www.whocc.no/atcddd. Accessed 9 September 2007.
Rowland M, Tozer T. Clinical pharmacokinetics: concepts and applications. 3rd ed. Baltimore: Lippincott Williams and Wilkins; 2005.
Blix HS, Engeland A, Litleskare I, et al. Age- and gender-specific antibacterial prescribing in Norway. J Antimicrob Chemother. 2007;59:971–6.
Majeed A, Moser K. Age- and sex-specific antibiotic prescribing patterns in general practice in England and Wales in 1996. Br J Gen Pract. 1999;49:735–6.
Guay DRP. Contemporary management of uncomplicated urinary tract infections. Drugs. 2008;68:1169–205.
Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ. 2006;332:94–7.
Bishai W. Current issues on resistance, treatment guidelines, and the appropriate use of fluoroquinolones for respiratory tract infections. Clin Ther. 2002;24:838–50.
Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med. 2000;160:1399–408.
Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–54.
Powers JH, Phoenix JA, Zuckerman DM. Antibiotic uses and challenges—a comprehensive review from NRCWF. Medscape Family Medicine. 2010. Available at: http://www.medscape.com/viewarticle/723457.
Gagliotti C, Mazzetti I, Moro ML. Comparison of sales and reimbursement data regarding outpatient antibiotic use in a northern Italian Region. Pharmacoepidemiol Drug Saf. 2009;18:1115–8.
Acknowledgments
Carlotta Franchi holds a fellowship granted by Rotary Clubs Milano Naviglio Grande San Carlo, Milano Scala, and Inner Wheel Milano San Carlo. We are grateful to Chiara Pandolfini for the language editing. This work was supported by grants from the Regional Health Ministry of the Lombardy region (Progetto ‘Epidemiologia dei farmaci-EPIFARM’).
Conflict of interest
None of the authors have anything to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Franchi, C., Sequi, M., Bonati, M. et al. Differences in outpatient antibiotic prescription in Italy’s Lombardy region. Infection 39, 299–308 (2011). https://doi.org/10.1007/s15010-011-0129-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-011-0129-1